Lindsay Clinics Limited - Period Ending 2022-03-31

Lindsay Clinics Limited

Contents

Company Information	1
Balance Sheet	2 to 3
Notes to the Unaudited Financial Statements	2

Lindsay Clinics Limited

Company Information

Directors

N J Simpson F J Topping

Registered office

Studio 3 102 The Leather Market Weston Street London SE1 3ER

Lindsay Clinics Limited

(Registration number: 13227990)
Balance Sheet as at 31 March 2022

	2022 £
Current assets	210,984
Prepayments and accrued income	1,614
Creditors: Amounts falling due within one year	(98,834)
Total assets less current liabilities	113,764
Accruals and deferred income	(1,800)
	111,964
Capital and reserves	111,964

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Studio 3
102 The Leather Market
Weston Street
London
SE1 3ER

These financial statements were authorised for issue by the Board on 9 November 2022.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2	Staff numbers

The average number of persons employed by the company (including directors) during the period, was 4.

Lindsay Clinics Limited

(Registration number: 13227990)
Balance Sheet as at 31 March 2022

For the financial period ending 31 March 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 9 November 2022 and signed on its behalf by:
 

......................................... N J Simpson Director

......................................... F J Topping Director